Antihypertensive Treatment for Elderly Patients

Initial Treatment Selection

• The European Society of Cardiology recommends thiazide diuretics as the preferred first-line agent for elderly patients, particularly those over 80 years old, as they have the strongest evidence for reducing cardiovascular morbidity and mortality in this age group 1, 2
• Dihydropyridine calcium channel blockers, such as amlodipine, are equally acceptable as first-line alternatives, particularly for isolated systolic hypertension 1, 2

Dosing Strategy for Very Elderly Patients

• The European Society of Cardiology suggests beginning with the lowest available dose and titrating gradually over 4-week intervals to minimize adverse effects, especially orthostatic hypotension and electrolyte disturbances 2, 4

Second-Line Agent Selection

• The European Society of Cardiology recommends adding a dihydropyridine calcium channel blocker, such as amlodipine, to a thiazide diuretic if blood pressure remains uncontrolled on monotherapy 1, 2
• The combination of a thiazide diuretic with a calcium channel blocker is one of the preferred two-drug regimens supported by guideline evidence 1, 2

Alternative Second-Line Options

• The European Society of Cardiology suggests that ACE inhibitors or angiotensin receptor blockers can be added if calcium channel blockers are not tolerated 1, 2, 4
• The combination of an ACE inhibitor or ARB with a thiazide diuretic is another evidence-based option 1, 2

Blood Pressure Targets

• The European Society of Cardiology recommends a target blood pressure of <140/90 mmHg if tolerated in patients over 80 years old 2, 4

Critical Monitoring Requirements

• The European Society of Cardiology suggests always measuring blood pressure in both sitting and standing positions to assess for orthostatic hypotension, which is common in the very elderly 2, 4

Three-Drug Regimen if Needed

• The European Society of Cardiology recommends adding a third agent from a different class, typically an ACE inhibitor or ARB if not already used, if blood pressure remains uncontrolled on two drugs 1, 2

Important Caveats

• The European Society of Cardiology advises against combining two renin-angiotensin system blockers, as this increases adverse effects without significant benefit 5
• Treatment decisions should account for comorbidities, target organ damage, and other cardiovascular risk factors that are frequent in the elderly 1, 2, 4